The bark of Norway spruce (Picea abies) contains up to 13% pectins that can be extracted by pressurized hot water, which constitute a valuable renewable resource in second-generation lignocellulosic biorefineries. This article proposes, for the first time, structural molecular models for the pectins present in spruce bark. Pectin fractions of tailored molar masses were obtained by fractionation of the pressurized hot water extract of the inner bark using preparative size-exclusion chromatography. The monosaccharide composition, average molar mass distribution, and the glycosidic linkage patterns were analyzed for each fraction. The pectin fraction with high molecular weight (Mw of 59,000 Da) contained a highly branched RG-I domain, which accounted for 80% of the fraction and was mainly substituted with arabinan and arabinogalactan (type I and II) side chains. On the other hand, the fractions with lower molar masses (Mw = 15,000 and 9000 Da) were enriched with linear homogalacturonan domains, and also branched arabinan populations. The integration of the analytical information from the macromolecular size distributions, domain composition, and branch lengths of each pectin fraction, results in a comprehensive understanding of the macromolecular architecture of the pectins extracted from the bark of Norway spruce. This paves the way for the valorization of spruce bark pectic polymers in targeted applications based on their distinct polymeric structures and properties.Based on additive manufacturing of wood flour and polyhydroxyalkanoates composites using micro-screw extrusion, device and process parameters were evaluated to achieve a reliable printing. The results show that the anisotropy of samples printed by micro-screw extrusion is less obvious than that of filament extrusion fused deposition modeling. The type of micro-screw, printing speed, layer thickness, and nozzle diameter have significant effects on the performance of printed samples. The linear relationship between the influencing parameters and the screw speed is established, therefore, the performance of printed products can be controlled by the extrusion flow rate related to screw speed.Limited information is available on the morphological characteristics of adult female footballers, therefore the aim of this article was to examine if there are position-specific differences in the morphological characteristics of sub-elite female football players and to establish normative standards for this level of female football players. The morphological features of 101 sub-elite female football players (age 21.8 ± 2.7 years) were assessed. Twenty anthropometric sites were measured for body composition and somatotype. The average value of body fat percentage was 20.8 ± 5.7%. The somatotype of the overall group was 4.0-2.4-2.1. Significant (p ≤ 0.05) differences were found between goalkeepers and outfield players in morphological characteristics. Goalkeepers were taller (166.2 ± 8.4 cm), heavier (66.5 ± 5.1 kg), possessed the highest body fat percentage (17.2 ± 6.2%) and showed higher values for all skinfold (sum of 6 skinfolds = 125.6 ± 45.9 cm), breadth, girth and length measurements. However, there were very few practically worthwhile differences between the outfield positions. Positional groups did not differ (p ≤ 0.05) in somatotype characteristics either. The study suggests that at sub-elite level there are mainly differences between goalkeepers and outfield players, but outfield players are homogeneous when comparing morphological characteristics. These results may serve as normative values for future comparisons regarding the morphological characteristics of female football players.T1 glottic cancer is a highly treatable disease with local control (LC) rates over 90% by either primary radiotherapy (pRT) or transoral laser microsurgery (TLM). LC of T2 glottic cancers is 15 percent points poorer on average. However, salvage after pRT entails more than 50% total laryngectomy. Therefore, there is a need for enhanced LC. Altered fractionation regimens improved LC in T1 but not in T2. For this reason, for T2, alternative strategies must be considered. In a large observational cohort study including 531 early-stage laryngeal cancers, a small number of patients were treated with primary chemoradiotherapy (pCRT). In multivariable analysis, factors associated with significantly poorer outcomes included age, comorbidities, supraglottic localization, and T category. While there was a significant difference between pRT and surgery (HR 1.79; 95%-CI 1.15-2.79), there was none between pCRT and surgery (HR 0.70; 95%-CI 0.33-1.51). There is evidence from the literature that pCRT in early glottic cancers could yield results that surpass the limits so far experienced in radiotherapy alone with acceptable toxicity. Thus, prospective randomized studies with larger numbers of patients are warranted.The nonoxidative conversion of ethanol to acetaldehyde under thermal and microwave heating was studied on mixed oxide ZnO-CuO-SiO2 catalysts modified with additives of tungsten carbide nanoparticles. The results revealed that the WC-modified catalyst exhibited superior activity and selectivity under microwave heating conditions. AZD1480 in vivo It is assumed that when microwave heating is used, hot zones can appear at the contact points of WC nanoparticles and active centers of the mixed oxide ZnO-CuO-SiO2 catalyst, which intensively absorb microwave energy, allowing the more efficient formation of acetaldehyde at moderate temperatures. Thermodynamic calculations of equilibrium concentrations of reagents and products allowed us to identify the optimal conditions for effective acetaldehyde production. The initial catalyst and the catalyst prepared by the coprecipitation of the oxides with the addition of WC were characterized by physicochemical methods (TPR-H2, XRD, DRIFTS of adsorbed CO). The active centers of the oxide catalyst can be Cu+ cations.The authors would like to correct an omission in a published paper [...].
This study assessed the antitumoral activity of the MEK inhibitor trametinib (TMT212) and the ERK1/2 inhibitor SCH772984, alone and in combination with the CDK4/6 inhibitor ribociclib (LEE011) in human neuroendocrine tumor (NET) cell lines in vitro.
Human NET cell lines BON1, QGP-1, and NCI-H727 were treated with trametinib or SCH772984, alone and in combination with ribociclib, to assess cell proliferation, cell cycle distribution, and protein signaling using cell proliferation, flow cytometry, and Western blot assays, respectively.
Trametinib and SCH772984, alone and in combination with ribociclib, significantly reduced NET cell viability and arrested NET cells at the G1 phase of the cell cycle in all three cell lines tested. In addition, trametinib also caused subG1 events and apoptotic PARP cleavage in QGP1 and NCI-H727 cells. A western blot analysis demonstrated the use of trametinib alone and trametinib in combination with ribociclib to decrease the expression of pERK, cMyc, Chk1, pChk2, pCDK1, CyclinD1, and c-myc in a time-dependent manner in NCI-H727 and QGP-1 cells.AZD1480 in vivo
Top comments (0)